SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bharat H. Barai who wrote (354)1/9/1998 9:35:00 AM
From: Jeff Clegg  Read Replies (1) of 442
 
Dr. Barai,

When Somatogen says that the data is being analyzed from the
first phase of the CPB studies, specifically what data?

Having spoken with SMTG several times myself, I understand that
the first phase has two parts: Part A is 1-2 units for patients
undergoing their first surgery and Part B is 1-2 units for
patients that are undergoing their second surgery (smaller
population to choose from). ARE BOTH PARTS A AND B COMPLETE?

I understand Part A has been completed but what about Part B?
If so, then when the news hits it should bounce the stock a bit,
else back to waiting.

Regards,
Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News